Colistimethate sodium supplier

Name
COLISTIN METHANESULFONATE SODIUM SALT
EINECS 232-516-9
CAS No. 8068-28-8
Density
Solubility Freely soluble in water
Melting Point
Formula C₅₈H₁₀₅N₁₆Na₅O₂₈S₅
Boiling Point
Molecular Weight 1749.82
Flash Point
Transport Information
Appearance
Safety
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms Colistinmethanesulfonicacid (6CI);Colimycin M;Colimycin sodium methanesulfonate;Colistimethate;Colistinsodium methanesulfonate;Colistin sulfomethate;Colistin sulfomethate sodium;Colistin, methyl sulfate, sodium salt;Colistinat;Coly-Mycin injectable;Colymycin M;Sodium colistimethate;Sodium colistinmethanesulfonate;W 1929;
PSA 0.00000
LogP 0.00000

Colistimethate sodium Consensus Reports

SODIUM COLISTINEMETHANESULFONATE is reported in EPA TSCA Inventory.

Colistimethate sodium Specification

The Colistimethate sodium, with the CAS registry number 8068-28-8, is also known as Colistinemethanesulfonate sodique. Its EINECS number is 232-516-9. This chemical's molecular formula is C₅₈H₁₀₅N₁₆Na₅O₂₈S₅ and molecular weight is 1749.82. What's more, its systematic name is Pentasodium [(4-{[3-(1-hydroxyethyl)-12,15-diisobutyl-2,5,8,11,14,17,20-heptaoxo-6,9,18-tris{2-[(sulfonatomethyl)amino]ethyl}-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]amino}-3-{[3-hydroxy-2-({2-[ (6-methyloctanoyl)amino]-4-[(sulfonatomethyl)amino]butanoyl}amino)butanoyl]amino}-4-oxobutyl)amino]methanesulfonate. Its classification codes are: (1)Antibacterial; (2)Drug / Therapeutic Agent; (3)Human Data; (4)Reproductive Effect.

You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].[Na+].[Na+].[Na+].[Na+].O=S([O-])(=O)CNCCC(NC(=O)CCCCC(C)CC)C(=O)NC(C(=O)NC(C(=O)NC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC1)C(O)C)CCNCS([O-])(=O)=O)CCNCS([O-])(=O)=O)CC(C)C)CC(C)C)CCNCS([O-])(=O)=O)CCNCS([O-])(=O)=O)C(O)C
(2)Std. InChI: InChI=1S/C58H110N16O28S5.5Na/c1-9-35(6)12-10-11-13-46(77)65-38(14-20-59-28-103(88,89)90)53(82)74-48(37(8)76)58(87)70-41(17-23-62-31-106(97,98)99)50(79)68-43-19-25-64-57(86)47(36(7)75)73-54(83)42(18-24-63-32-107(100,101)102)67-49(78)39(15-21-60-29-104(91,92)93)69-55(84)44(26-33(2)3)72-56(85)45(27-34(4)5)71-52(81)40(66-51(43)80)16-22-61-30-105(94,95)96;;;;;/h33-45,47-48,59-63,75-76H,9-32H2,1-8H3,(H,64,86)(H,65,77)(H,66,80)(H,67,78)(H,68,79)(H,69,84)(H,70,87)(H,71,81)(H,72,85)(H,73,83)(H,74,82)(H,88,89,90)(H,91,92,93)(H,94,95,96)(H,97,98,99)(H,100,101,102);;;;;/q;5*+1/p-5
(3)Std. InChIKey: IQWHCHZFYPIVRV-UHFFFAOYSA-I

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
child	LDLo	intramuscular	90mg/kg/18H-I (90mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED	JAMA, Journal of the American Medical Association. Vol. 207, Pg. 2099, 1969.
guinea pig	LD50	intramuscular	444mg/kg (444mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 21, Pg. 737, 1981.
human	TDLo	intramuscular	56700ug/kg/9D (56.7mg/kg)	KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"	Annals of Internal Medicine. Vol. 66, Pg. 1052, 1967.
mouse	LD50	intramuscular	748mg/kg (748mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 21, Pg. 737, 1981.
mouse	LD50	intraperitoneal	126mg(base)/k (126mg/kg)		Antibiotics Annual. Vol. 7, Pg. 41, 1959/1960.
mouse	LD50	intravenous	222mg(base)/k (222mg/kg)		Antibiotics Annual. Vol. 7, Pg. 41, 1959/1960.
mouse	LD50	oral	> 767mg(base)/ (767mg/kg)		Antibiotics Annual. Vol. 7, Pg. 41, 1959/1960.
mouse	LD50	subcutaneous	138mg(base)/k (138mg/kg)		Antibiotics Annual. Vol. 7, Pg. 41, 1959/1960.
rabbit	LD50	intramuscular	465mg/kg (465mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 21, Pg. 737, 1981.
rat	LD50	intramuscular	44mg/kg (44mg/kg)		Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
rat	LD50	intraperitoneal	86mg/kg (86mg/kg)	LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 541, 1973.
rat	LD50	oral	5450mg/kg (5450mg/kg)	LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 541, 1973.
rat	LD50	subcutaneous	87mg/kg (87mg/kg)	LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 541, 1973.

Product Name

COLISTIN METHANESULFONATE SODIUM SALT

Colistimethate sodium Consensus Reports

Colistimethate sodium Specification

Related Products

Hot Products